glp 1 kidney GLP-1 receptor agonists are increasingly used to treat type 2 diabetes and obesity, and trials have shown reductions in cardiovascular risk and slowing of failure. Adverse events are mostly gastrointestinal GLP-1s lower BMI, preserve kidney

As you may have guessed, the culprit behind these symptoms is stress

The researchers warned the medications growing popularity among those with obesity could be exacerbating a nationwide drug shortage, and also raises concerns about the need to ensure that patients with diabetes still have access to these treatments, Dr

Gia McCloskey-Jurevich, NP , provides individualized, knowledgeable care, helping you navigate the options to find what works best for your body

While the later emphasized a dose-response effect and found no role for follow-up, however, we observed no consistent dose gradient but did find that longer follow-up linked to greater improvement on self-reported symptoms (BDI only)